CALL - SPRINTER OPEN END - EDWARDS LIFESCIENCES | Delayed Deutsche Boerse AG 01:53:48 02/07/2024 pm IST | ||
| 3.26 EUR | -2.40% |
|
| Current month | -6.70% | ||
| 1 month | +13.61% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 02/24/02 | 3.26 | -2.40% |
| 01/24/01 | 3.34 | -6.70% |
| 28/24/28 | 3.58 | -1.10% |
| 27/24/27 | 3.62 | +5.23% |
| 26/24/26 | 3.44 | +2.99% |
Delayed Quote Deutsche Boerse AG
Last update July 02, 2024 at 01:53 pm IST
More quotesStatic data
| Product type | Knock-Out sin Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
Vontobel
|
| WKN | VM55H9 |
| ISIN | DE000VM55H97 |
| Date issued | 29/11/2023 |
| Strike | 55.04 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.43 € |
| Emission volume | N/A |
| Settlement | Por diferencias |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.91 € |
|---|---|
| Lowest since issue | 1.35 € |
| Spread | 0.07 € |
| Spread % | 2.10% |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
90.25
USD
Average target price
96.05
USD
Spread / Average Target
+6.43%
- Stock Market
- Certificates
- Certificat
